Msp1-mediated phosphorylation of Megator disrupts its interaction with Mad1. (A and B) Western blot analysis of Mad1 immunoprecipitates (IP; A) and Megator hyperphosphorylation (B) from lysates of asynchronous and mitotically enriched (+ colchicine) control and Mps1-depleted S2 cells. When indicated, lysates were treated with λ-phosphatase (λPP). (C) In vitro kinase assay with recombinant MBP-Megator fragments and GST-Mps1 in the presence of [γ-32P]ATP. (D) Schematic representation of Drosophila Megator (ELM resource) and Clustal Omega (EMBL-EBI) local sequence alignment for the indicated Megator/Tpr orthologues. Residues conservation: *, fully conserved;:, strongly similar properties;., weakly similar properties. Residues phosphorylated by Mps1 (P) were identified by MS analysis after in vitro kinase assay. (E and F) Pull-downs of recombinant MBP-Megator1,187–1,655 fragments by bead-immobilized 6xHis-Mad11–493 or 6xHis-BubR11–358 (negative control; E) and corresponding quantifications (F) from two independent experiments. B, beads; FT, flow-through. (G and H) Immunofluorescence images (G) and schematic representation (H) of EGFP-Megator1,187–1,655 clustering by LARIAT in mitotic S2 cells. EGFP-aPKC was used as negative control. (I and J) Quantification of Mad1 levels at EGFP-Megator1,187–1,655 clusters (n ≥ 114 clusters; I) and at KTs (n ≥ 64 KTs; J). In F, I, and J, data are presented as mean ± SD. **, P < 0.01; ****, P < 0.0001 (Kruskal–Wallis, Dunn’s multiple comparison test). Scale bars, 5 µm (inset, 1 µm).